Drugmaker Merck says it will soon ask U.S. health officials to authorize use of an experimental COVID-19 pill that Merck says reduces hospitalizations and deaths by half. A Food and Drug Administration decision could come within weeks after that. (Oct. 1)
Subscribe for more Breaking News: [ Ссылка ]
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
